STAAR Surgical Company  

(Public, NASDAQ:STAA)   Watch this stock  
Find more results for STAA
May 22 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range     -
52 week 4.84 - 17.30
Open     -
Vol / Avg. 0.00/208,727.00
Mkt cap 352.71M
P/E     -
Div/yield     -
EPS -0.24
Shares 38.85M
Beta 0.45
Inst. own 80%
Jul 29, 2015
Q2 2015 STAAR Surgical Company Earnings Release (Estimated) - 4:00PM EDT - Add to calendar
May 7, 2015
STAAR Surgical Company at Deutsche Bank Health Care Conference
Apr 29, 2015
Q1 2015 STAAR Surgical Company Earnings Call - Webcast
Apr 29, 2015
Q1 2015 STAAR Surgical Co Earnings Release
Feb 25, 2015
Q4 2014 STAAR Surgical Co Earnings Call - Webcast
Feb 25, 2015
Q4 2014 STAAR Surgical Co Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q2 (Apr '15) 2015
Net profit margin -12.41% -11.19%
Operating margin -8.01% -10.70%
EBITD margin - -7.42%
Return on average assets -16.22% -13.89%
Return on average equity -25.56% -22.10%
Employees 300 -
CDP Score - -


1911 Walker Ave
United States - Map
+1-626-3037902 (Phone)
+1-626-3032962 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


STAAR Surgical Company (STAAR) designs, develops, manufactures and sells implantable lenses for the eye and delivery systems used to deliver lenses into the eye. The Company makes lenses used in corrective or refractive surgery, and make lenses for use in surgery that treats cataracts. Activities outside the United States accounted for approximately 82% of its total sales in Fiscal 2013, due to the pacing of product approvals and commercialization that tend to occur outside the United States, STAAR sells its products in more than 60 countries, with direct distribution in the United States, Canada, Japan and Spain. STAAR has initiated a project to consolidate all of its manufacturing to its Monrovia, California facility. STAAR, Visian, Collamer, CentraFlow, AquaPort, nanoFLEX, nanoPOINT, Epiphany, and AquaFlow are trademarks or registered trademarks of STAAR in the United States and other countries. Collamer is the brand name for STAAR’s proprietary collagen copolymer lens material.

Officers and directors

Mark B. Logan Independent Chairman of the Board
Age: 75
Bio & Compensation  - Reuters
Caren L. Mason President, Chief Executive Officer, Director
Bio & Compensation  - Reuters
Stephen P. Brown Chief Financial Officer, Vice President
Age: 54
Bio & Compensation  - Reuters
Hans-Martin Blickensdoerfer President, International Commercial Operations
Age: 50
Bio & Compensation  - Reuters
Donald J. Todd President, Asia Pacific
Age: 61
Bio & Compensation  - Reuters
Deborah J. Andrews Chief Accounting Officer, Vice President
Age: 56
Bio & Compensation  - Reuters
Paul Hambrick Vice President - Global Operations
Age: 51
Bio & Compensation  - Reuters
Philippe Subrin Vice President - Switzerland Operations
Age: 50
Bio & Compensation  - Reuters
Samuel J. Gesten Vice President, General Counsel, Corporate Compliance Officer and Secretary
Age: 52
Bio & Compensation  - Reuters
Donald Lee Fagen Vice President - North American Sales
Age: 60
Bio & Compensation  - Reuters